Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SA, Yep… right over… lol… eom
SA, Do the math… what size R/S would be required to get ENZC to $10/sh? Oh, and how could that happen and still retain the original share count? It couldn’t without the Sagaliam deal. Go figure…
Any of you complaining about the Sagaliam deal happen to have an extra $450 Million laying around to replace Sagaliam? ……..No?…….. I didn’t think so…
TBT, “Safari cannot open the page because the address is invalid.”
Dear Shareholders,
As we close the chapter on 2023, I am delighted to share with you the remarkable journey and accomplishments we've achieved at Hycroft Mining throughout the year. This year has been marked by significant developments that underscore our commitment to unlocking value and advancing the Hycroft Mine, one of the largest gold and silver deposits in the world.
The year 2023 has been a testament to our commitment to operational excellence and fostering a safe and healthy work environment. Our unwavering dedication to safety remained at the forefront, ensuring the well-being of our workforce while delivering on our objectives. I am proud to report that Hycroft won several awards throughout the year highlighting this commitment and that our safety record is one of the best in the industry. We have maintained a ZERO Total Reportable Injury Frequency Rate (“TRIFR”) for two full calendar years and in November surpassed 2 million man-hours without a Lost Time Injury (“LTI”). Safety is our top priority at Hycroft, so please join me in applauding our team for ensuring everyone goes home safe every day.
The completion of the Hycroft Property Initial Assessment Technical Report Summary ("2023 Hycroft TRS") in March was a meaningful achievement that outlined one of the largest precious metals resources in the world. The report highlighted Measured and Indicated resources of 10.6 million ounces of gold and 360.7 million ounces of silver, along with Inferred resources of 3.4 million ounces of gold and 96.1 million ounces of silver. With gold and silver closing the year at all-time highs, our leverage to these strong tailwinds as we go into 2024 is incredibly meaningful for any mining investment portfolio.
A resource of this size requires a rigorous approach to the technical studies required to bring the asset into production. To that end, we have been advancing the work necessary for the completion of a prefeasibility study, which includes extensive trade off studies as well as metallurgical test work. Earlier in the year we announced positive metallurgical flotation variability results with average flotation recoveries 10% higher than previously modeled: 89% for gold and 93% silver. Work is ongoing and we look forward to sharing more results with you in the months to come.
Now, I know I am biased, but I would argue that we have one of the best teams in the industry right now. This team is looking at Hycroft through a different lens, challenging expectations and working to uncover Hycroft’s untold story. A key piece to that story lies to the south of the known resource – the high-grade Rosebud Mine. In May we announced the strategic acquisition of claims near Rosebud, which provided us with invaluable data that has significantly enriched our understanding of the Hycroft deposit and surrounding area. With this data we have amplified our ability to target key areas within the corridor between the Hycroft Mine and Rosebud, areas we view as highly prospective in relation to the high-grade silver systems we have been encountering throughout the year.
Which brings me to what I view as the most exciting news we have had in 2023: the high-grade silver discoveries made across the Hycroft system. In 2022, we launched the largest exploration program in over a decade and throughout 2023 Phase 2 of that program has yielded exceptional results, expanding the Hycroft system and discovering elevated silver across various zones. These results have the potential to change the outlook for the Hycroft Mine. Notably, the Vortex zone continues to exhibit high-grade silver at depth, with drill results surpassing average silver resource grades by 15 times. Moreover, the discovery of a new high-grade silver system at Brimstone, marked by H23R-5753 – the best hole ever drilled at Hycroft – represents a pivotal moment in Hycroft's history, revealing significant silver mineralization that surpasses prior understandings of our mine's potential.
As we head into 2024, our team of incredibly talented geologists, led by VP of Exploration Alex Davidson, will use all of the data collected in 2023 to continue homing in on these high-grade silver zones with the objective of confirming continuity and piecing together what this could mean in terms of the economics of the project. Our hope is that if we can confirm continuity of the mineralization, we can outline a high-grade silver deposit that could be the basis for a high-grade starter mine, which would propel Hycroft towards operations. This technical team is working tirelessly to generate and deliver value to you, our shareholders and are extremely enthusiastic about the positive results from our work to date.
As we reflect on these achievements, we extend our sincere appreciation to you, our shareholders, for your steadfast support and confidence in our endeavors. Looking forward, we remain resolute in our commitment to delivering sustainable value and driving continued success in the years to come.
Thank you for being an integral part of Hycroft Mining's journey.
With warm regards,
Diane R. Garrett
President & CEO
Portugal’s Judiciary Police Enhances Security Infrastructure via Securnet and BIO-key
HOLMDEL, N.J. and LISBON, Portugal, Jan. 02, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the Judiciary Police of Portugal (Polícia Judiciária) has significantly enhanced its operational security by implementing a robust Virtual Private Network (VPN) secured by BIO-key Swivel Secure authentication technology AuthControl Sentry. The deployment was sourced through BIO-key’s strategic collaboration with Securnet.
The VPN, along with an advanced Access Control Device system provided by Securnet, significantly augments the security and efficiency of communications and data access for the Judiciary Police. The technologies support key infrastructure supporting the relentless fight against organized crime, terrorism, drug trafficking, corruption, as well as economic and financial crimes.
“The Judiciary Police’s commitment to advanced technological solutions is commendable,” said Alex Rocha, Managing Director of BIO-key Europe. “Our involvement in this project, through our partnership with Securnet, demonstrates the adaptability and strength of our security solutions in high-stakes environments. This collaboration is a prime example of how cutting-edge technology can empower law enforcement agencies to perform their critical duties more securely and effectively.”
“The implementation of these security solutions, facilitated by our collaboration with Securnet was pivotal in maintaining the integrity of communications. These technologies play a vital role in safeguarding information systems and operations, which are essential in the fight against sophisticated criminal networks.”
About Securnet (www.securnet.pt)
Founded in 2002 with the mission of putting organizations “Always online, Always Secure”, Securnet has evolved into a complete provider of IT infrastructure solutions and services. The excellence of Securnet solutions and services is widely recognized by customers and manufacturers as generators of value, innovation and competitiveness. Betting on transparent, trustworthy and long-term relationships, supported by an experienced, efficient, specialized and certified technical team, Securnet is a preferred supplier and technological partner of an increasing number of customers across a diverse range of sectors and industries.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
About the Judiciary Police (www.policiajudiciaria.pt)
The Polícia Judiciária (PJ; English: Judiciary Police) is the national criminal investigation police agency of Portugal, focused in fighting serious crimes, including homicides, kidnapping, organized crime, terrorism, illegal drug trade, corruption, cybercrime and financial crime. It is integrated into the Ministry of Justice, but operates under the supervision of the Public Ministry.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
DRHUMI, 8K’s are not required on the OTC. eom
tulia236a, … and a few employees from the SEC and FINRA might make that “taken down” list as well…
Aw1416, Yes, I notice it’s just me here. Oh, and I don’t own any BKYI. It’s a long story…
Those buying back in better slap that Ask because it will cost twice as much next week… GLTA!
FOMO kicking in… over $ .02+, tomorrow… GLTA!
I like seeing INTL on the bid… eom
Carrefour Strengthens Enterprise Cybersecurity in Spain with BIO-key’s AuthControl Sentry® Cloud Solution in Partnership with Evolutio
HOLMDEL, N.J. and MADRID, Spain, Dec. 27, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced today that Carrefour, a leading global retailer, is integrating BIO-key’s AuthControl Sentry® cloud solution in Spain in collaboration with Evolutio, a trusted partner of BIO-key’s Swivel Secure Europe subsidiary. The strategic collaboration is part of Carrefour’s ongoing commitment to operational excellence and data security.
AuthControl Sentry is now a key component in safeguarding the authentication process for Carrefour’s 6,500 Spanish employees. The solution protects access to critical services and reinforces the company’s dedication to the highest standards of data security and privacy.
Alex Rocha, Managing Director of BIO-key Europe, commented, “We are honored to have leading global retailer Carrefour implement our AuthControl Cloud Sentry solution in Spain. This collaboration, facilitated by our partner Evolutio, showcases the security, versatility and reliability of our products in meeting the complex cybersecurity needs of large-scale organizations. BIO-key Europe is committed to delivering top-tier security solutions that empower businesses like Carrefour to operate with confidence and resilience in an increasingly digital world. Our AuthControl solution not only enhances operational efficiency but also ensures the utmost security for our customers, their employees and critical data.”
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
About Evolutio (www.evolutio.com/)
Evolutio is the trusted technological partner that any company needs. Evolutio consultants are experts in the integration of cloud services for multinational and domestic companies in the Spanish market. Its objective is to boost the agility, flexibility and capacity for innovation of clients, helping them to achieve the maximum possible value from their business and accompanying them in their digitization process. Headquartered in Madrid, Evolutio has a track record of over 30 years of experience in the IT sector.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
$ETEK I like the stock… eom
Oh, I need to add that lots of investors agree with me. The financial community is writing articles about how AMC is eliminating debt, and improving the balance sheet. This is getting better every day! Boomage soon! Let’s GO!!
SPK, Agree… time is all it takes…. eom
Anyone else get the feeling that $AMC is about to take off based on fundamentals, not MOASS? If it does, then MOASS will likely happen. GLTA!
SPK, Nice! eom
It would be nice if Charles could hold hands with all the stockholders while they sing “Kumbaya”… yeah… right… I don’t think I’ve ever seen such a bunch of whimpy stockholders as are here on this message board.
At one point you complain that the SAGA deal is cheating you, and then you complain that the SAGA deal is not going to happen. Pffffft… grow a pair and realize that this is an OTC company trying to get to NASDAQ one way or the other. In spite of all the odds against this company, it is still going forward with its IP. The IP is what makes this company valuable. If you do not respect that, then move on. As for me, I am buying as much of this stock as I can … ‘nuf said.
“Could AMC Be The Next Carvana?”
https://www.thestreet.com/memestocks/amc/could-amc-stock-be-the-next-carvana-stock-in-2024
I have to say as a “rider of the OTC” for many years, I am really enjoying the repetitive opportunities presented here… GLTA!
Really, Do you really think the APES have left? It’s getting down to the point where Citadel and Bank of America will implode. It will be EPIC!
Join the petition… https://chng.it/vzXgdDLdDG
Investigate Citadel!
BIO-key Repays $2.2M Senior Secured Note
HOLMDEL, N.J., Dec. 21, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced today that it has repaid its $2.2M senior secured note in full, eliminating all long-term debt and has completed a $550,000 private placement of units at a premium to market. Each unit in the placement included one share of common stock or a prefunded warrant in lieu thereof and one common warrant to purchase one and one half shares of common stock at a presplit price of $0.175 per unit ($3.15 on a post-split basis). Each common warrant is exercisable at a presplit price of $0.175 per share ($3.15 on a post-split basis).
BIO-key CEO Michael DePasquale commented, “We are working to put BIO-key on a strong financial footing for continued growth and improving bottom-line performance in 2024 and beyond. These efforts include the completion of $4.3M in equity funding over the past two months. Proceeds from these offerings have strengthened our cash and liquidity position while also enabling us to retire a $2.2M note issued and held by AJB Capital Investments.
“Given our progress to date this year, we are optimistic about our outlook for 2024. Over the last four completed quarters , we grew revenues 39% to $8.6M. and in Q3’23 we reduced our net loss to $638,000 from a net loss of $2.4M in Q3’22. Given our operating improvements and new capital, we believe we are well positioned to build on this progress in 2024. Our optimism is supported by increasing quote activity and deal sizing; our expanding base of recurring revenues; and our expanding global Channel Alliance Partner program.”
Following the 1-for-18 reverse stock split effective with the commencement of trading on December 21, 2023, BIO-key will have approximately 1 million shares of common stock issued and outstanding and approximately 1.9 million common stock equivalents inclusive of prefunded warrants.
The securities issued in the private placement were not registered under the Securities Act of 1933, as amended. Accordingly, these securities may not be offered or sold in the United States, except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
Guess where all those “air” shares are coming from in order to keep the pps below $6.50. If the price just stays above $6.50, the shorts are screwed. Let’s GO! 🔥🩳🔥
Imo, the 9M SAGA shares issued to the four ENZC partners will have to be returned. After that, SAGA management will have to regroup to stay viable. GLTA!
SrApollo, Here’s the main problem: “Company’s failure to obtain shareholder approval in connection with an issuance resulting in a change of control”… imo, this will be reversed…
StocktonCA, ENZC shares… eom
Following Stockholder Approval, BIO-key Announces 1-for-18 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Price Requirement
WALL, N.J., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has approved a 1-for-18 reverse stock split that will become effective with the commencement of trading on December 21, 2023.
BIO-key stockholders approved a proposal last week to allow the Board to proceed with a reverse split to assist the Company in its effort to regain compliance with the minimum bid price requirement.
BIO-key had approximately 16.9 million shares of common stock issued and outstanding as of December 19, 2023. After giving effect to the 1-for-18 reverse stock split, BIO-key will have approximately 941,000 shares of common stock issued and outstanding.
BIO-key CEO Michael DePasquale commented, “We view our Nasdaq listing as an important stockholder and corporate asset. In order to regain compliance with Nasdaq’s $1 minimum closing bid price requirement, a reverse stock split was required. The Board’s decision to set the ratio at 1-for-18 was intended to position our common stock for ongoing minimum bid price compliance as we execute on our growth and profitability goals in 2024 and beyond.”
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy debt repayment obligations and working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
Engage with BIO-key:
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
My October 24th post: “$ .19… wow… I guess everyone is expecting another huge R/S….” … took management two months longer than I thought, but there it is….
BIO-key announces 1-for-18 reverse stock split to regain Nasdaq compliance
Dec. 19, 2023 8:28 AM ETBIO-key International, Inc. (BKYI) StockBy: Meghavi Singh, SA News Editor1 Comment
BIO-key (NASDAQ:BKYI) has approved a 1-for-18 reverse stock split that will become effective with the commencement of trading on December 21, 2023.
The reverse stock split is part of the company’s plan to regain compliance with the minimum bid price requirement for continued listing on Nasdaq.
The reverse stock split will reduce the number of issued common shares from approximately 16.9 million shares to approximately 941,000 shares.
Shares were down 12.83% to $0.15 in early trading on Monday
DR_rugby, Could be more like that coming… eom
Gollum Stocks, Swap postponed to January and then postponed again until March… hmmmm
konshe, The Bid size is larger than the Ask size.
Genesis HealthCare System Builds on its Investment in BIO-key Biometric Authentication Security as it Migrates to Epic Hyperdrive
ZANESVILLE, Ohio and HOLMDEL, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced that its longstanding customer Genesis HealthCare System, the largest healthcare provider in its six-county region of Ohio, will add BIO-key’s PortalGuard IAM platform to support its existing BIO-key biometric authentication investment as it migrates to Epic Systems’ Hyperdrive end-user application interface. Genesis HealthCare has a network of more than 300 physicians and 4,000 employees across 27 locations.
PortalGuard’s standards-based integration with Hyperdrive allows Genesis HealthCare System to continue enjoying the security and streamlined biometric authentication user experience that BIO-key provides without re-enrolling employees or adopting more cumbersome and expensive multi-factor authentication solutions.
Named by Computerworld as one of the 100 Best Places to Work in IT every year since 2017, Genesis Healthcare utilizes BIO-key biometric software and hardware to secure and streamline its users’ login experience for Epic. By deploying PortalGuard IAM, it is able to maintain a consistent user experience and simplify the Hyperdrive migration. PortalGuard fully supports Hyperdrive’s modern authentication approach through its SAML Identity Provider (IdP) capabilities. PortalGuard provides seventeen authentication factor options, including WEB-key fingerprint authentication, the same core BIO-key biometric authentication platform regularly used by thousands of Genesis HealthCare employees. Additionally, users can now use PortalGuard for biometric authentication in other hospital applications through its support for standard IdP integration options like SAML, OAUTH, and OpenID Connect.
"Epic is a mission-critical application for many of BIO-key’s hospital customers, and implementing PortalGuard SAML SSO allows Genesis to maintain streamlined workflows and ensure secure access to patient information with IBB," said Mark Cochran, President of BIO-key – PortalGuard. "Healthcare organizations face the challenge of providing convenient and reliable access to necessary systems while ensuring data privacy and regulatory compliance. BIO-key’s Identity-Bound Biometrics allows customers to cost-effectively leverage a phoneless, tokenless, and cardless authentication experience that users prefer because it strikes the proper balance between security and convenience."
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy debt repayment obligations and working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI @Bacchus-9800
BBalllegend, If you think what is happening here is illegal, then you need to see the big picture. Google Ken Griffin video where he admits that Citadel, Fidelity and others have been manipulating the price of stocks.
All this banter on this board contributes nothing to the progress of this company. Each post is just “sounding brass” either way. So, please, continue to contribute to the board your nothingness, OR, we.could have factual information posted as in the past, Please, post just new information to the betterment of the company.
bigtalan, I have, and will follow up for sure…eom
ckmseven788, An excellent entry point, imo… eom